StockNews.AI
IDXX
StockNews.AI
2 days

IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

1. IDEXX will present at Morgan Stanley Healthcare Conference on September 9, 2025. 2. Jay Mazelsky and Andrew Emerson will represent IDEXX during the fireside chat. 3. Live webcast and archived presentation available on IDEXX's investor relations website. 4. IDEXX is a leader in pet healthcare and diagnostic innovation. 5. Company employs 11,000 and operates in over 175 countries.

5m saved
Insight
Article

FAQ

Why Neutral?

The announcement does not indicate immediate changes in performance or valuation. Past events have shown that conference talks generally have neutral to low direct impact on stock prices.

How important is it?

The significance of this announcement is moderate; while it reflects IDEXX's engagement with the investment community, it does not signal any fundamental changes or performance indicators.

Why No Impact?

Being an event scheduled for 2025, it is too far out to trigger immediate market reactions. For instance, previous conference participation typically influences sentiment rather than immediate stock movement.

Related Companies

IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and Andrew Emerson, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025 from 1:50 pm – 2:25 pm (ET).

A live audio webcast of the presentation will be available through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the presentation will be available via the same link.

About IDEXX Laboratories, Inc.

IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500® Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visit www.idexx.com.

Investor Relations

investorrelations@idexx.com

Related News